- Home
- COEP vs IPWR Comparison
COEP vs IPWR Comparison
Compare COEP & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COEP | IPWR |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 42.8M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | COEP | IPWR |
|---|---|---|
| Price | $15.50 | $4.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.75 |
| AVG Volume (30 Days) | ★ 91.6K | 70.1K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,996.00 | $43,136.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3,233.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.31 | $3.06 |
| 52 Week High | $21.41 | $8.62 |
Technical Indicators
Market Signals| Indicator | COEP | IPWR |
|---|---|---|
| Relative Strength Index (RSI) | 45.46 | 50.54 |
| Support Level | $14.82 | $4.05 |
| Resistance Level | $16.45 | $4.50 |
| Average True Range (ATR) | 1.47 | 0.37 |
| MACD | -0.21 | 0.13 |
| Stochastic Oscillator | 4.78 | 79.17 |
Price Performance
Historical ComparisonAbout COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About IPWR Ideal Power Inc.
Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.